<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2023-9-4-0-3</article-id><article-id pub-id-type="publisher-id">3245</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;The link of single nucleotide polymorphism rs4880 of the &lt;em&gt;SOD2&lt;/em&gt; gene to the development of microvascular complications of type 2 diabetes mellitus&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;The link of single nucleotide polymorphism rs4880 of the &lt;em&gt;SOD2&lt;/em&gt; gene to the development of microvascular complications of type 2 diabetes mellitus&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Azarova</surname><given-names>Iuliia E.</given-names></name><name xml:lang="en"><surname>Azarova</surname><given-names>Iuliia E.</given-names></name></name-alternatives><email>azzzzar@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Gureeva</surname><given-names>Anastasia V.</given-names></name><name xml:lang="en"><surname>Gureeva</surname><given-names>Anastasia V.</given-names></name></name-alternatives><email>nastasyi.207@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Postnikova</surname><given-names>Mariia I.</given-names></name><name xml:lang="en"><surname>Postnikova</surname><given-names>Mariia I.</given-names></name></name-alternatives><email>postnikova0700@icloud.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Makarenko</surname><given-names>Victor V.</given-names></name><name xml:lang="en"><surname>Makarenko</surname><given-names>Victor V.</given-names></name></name-alternatives><email>vm200046@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Klyosova</surname><given-names>Elena Yu.</given-names></name><name xml:lang="en"><surname>Klyosova</surname><given-names>Elena Yu.</given-names></name></name-alternatives><email>ecless@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Polonikov</surname><given-names>Alexei V.</given-names></name><name xml:lang="en"><surname>Polonikov</surname><given-names>Alexei V.</given-names></name></name-alternatives><email>polonikov@rambler.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2023</year></pub-date><volume>9</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2023/4/НР_Медицина-45-57.pdf" /><abstract xml:lang="ru"><p>Background: The superoxide dismutase 2 (SOD2) gene encodes a mitochondrial enzyme whose main function is to convert superoxide anion to hydrogen peroxide. A genetically determined decrease in the activity of the SOD2 enzyme in the case of a single nucleotide variant rs4880 (A&amp;gt;G) may contribute to the development of redox imbalance in the mitochondria of beta cells of the pancreas and other tissues, which have pathogenic significance in the occurrence of type 2 diabetes mellitus (T2DM) and its microvascular complications. The aim of the study: To analyze the association of the missense variant rs4880 SOD2, leading to the replacement of valine with alanine in the protein product of the gene, with the risk of developing T2D and its microvascular complications &amp;ndash; diabetic retinopathy (DR) and nephropathy (DNF). Materials and methods: The study included 3206 subjects, residents of Central Russia, 1579 of whom were diagnosed with T2D. At the same time, DR was detected in 991 patients with T2D, and DNF was detected in 544 patients with T2D. Genotyping was performed by real-time polymerase chain reaction on a Bio-Rad CFX1000 thermal cycler using TaqMan probes. Statistical analysis of associations was performed using the SNPStats online program. Results: An association was established for the minor allele G (OR=1.26, 95% CI=1.02-1.56, P=0.033), as well as genotypes A/G and G/G rs4880 (OR=1.51, 95% CI=1.09-2.11, P=0.015) with a risk of developing DR in females with T2D. No statistically significant associations with T2D and the development of DNF were identified: P&amp;gt;0.05. Conclusion: Carriage of the minor allele rs4880-G is a genetic marker of an increased risk of developing diabetic retinopathy in females with T2D.</p></abstract><trans-abstract xml:lang="en"><p>Background: The superoxide dismutase 2 (SOD2) gene encodes a mitochondrial enzyme whose main function is to convert superoxide anion to hydrogen peroxide. A genetically determined decrease in the activity of the SOD2 enzyme in the case of a single nucleotide variant rs4880 (A&amp;gt;G) may contribute to the development of redox imbalance in the mitochondria of beta cells of the pancreas and other tissues, which have pathogenic significance in the occurrence of type 2 diabetes mellitus (T2DM) and its microvascular complications. The aim of the study: To analyze the association of the missense variant rs4880 SOD2, leading to the replacement of valine with alanine in the protein product of the gene, with the risk of developing T2D and its microvascular complications &amp;ndash; diabetic retinopathy (DR) and nephropathy (DNF). Materials and methods: The study included 3206 subjects, residents of Central Russia, 1579 of whom were diagnosed with T2D. At the same time, DR was detected in 991 patients with T2D, and DNF was detected in 544 patients with T2D. Genotyping was performed by real-time polymerase chain reaction on a Bio-Rad CFX1000 thermal cycler using TaqMan probes. Statistical analysis of associations was performed using the SNPStats online program. Results: An association was established for the minor allele G (OR=1.26, 95% CI=1.02-1.56, P=0.033), as well as genotypes A/G and G/G rs4880 (OR=1.51, 95% CI=1.09-2.11, P=0.015) with a risk of developing DR in females with T2D. No statistically significant associations with T2D and the development of DNF were identified: P&amp;gt;0.05. Conclusion: Carriage of the minor allele rs4880-G is a genetic marker of an increased risk of developing diabetic retinopathy in females with T2D.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>diabetes mellitus type 2</kwd><kwd>diabetic retinopathy</kwd><kwd>diabetic nephropathy</kwd><kwd>single nucleotide polymorphism</kwd><kwd>SOD2 gene</kwd><kwd>superoxide dismutase 2</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus type 2</kwd><kwd>diabetic retinopathy</kwd><kwd>diabetic nephropathy</kwd><kwd>single nucleotide polymorphism</kwd><kwd>SOD2 gene</kwd><kwd>superoxide dismutase 2</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Dedov II, Shestakova MV, Vikulova OK, et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204-221. Russian. DOI: https://doi.org/10.14341/DM12759</mixed-citation></ref><ref id="B2"><mixed-citation>Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice. 2022;183:109119. DOI: https://doi.org/10.1016/j.diabres.2021.109119</mixed-citation></ref><ref id="B3"><mixed-citation>Ali MK, Pearson-Stuttard J, Selvin E, et al. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2022;65(1):3-13. DOI: https://doi.org/10.1007/s00125-021-05585-2</mixed-citation></ref><ref id="B4"><mixed-citation>Singh A, Kukreti R, Saso L, et al. Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes. Molecules. 2022;27(3):950. DOI: https://doi.org/10.3390/molecules27030950</mixed-citation></ref><ref id="B5"><mixed-citation>Azarova I, Polonikov A, Klyosova E. Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 2023;24(5):4738. DOI: https://doi.org/10.3390/ijms24054738</mixed-citation></ref><ref id="B6"><mixed-citation>Azarova I, Klyosova E, Polonikov A. The Link between Type 2 Diabetes Mellitus and the Polymorphisms of Glutathione-Metabolizing Genes Suggests a New Hypothesis Explaining Disease Initiation and Progression. Life. 2021;11(9):886. DOI: https://doi.org/10.3390/life11090886</mixed-citation></ref><ref id="B7"><mixed-citation>Vilas-Boas EA, Almeida DC, Roma LP. Lipotoxicity and &amp;beta;-cell failure in type 2 diabetes: Oxidative stress linked to NADPH oxidase and ER stress. Cells. 2021;10(12):3328. DOI: https://doi.org/10.3390/cells10123328</mixed-citation></ref><ref id="B8"><mixed-citation>Dai W, Jiang L. Dysregulated mitochondrial dynamics and metabolism in obesity, diabetes, and cancer. Frontiers in Endocrinology. 2019;10:570. DOI: https://doi.org/10.3389/fendo.2019.00570</mixed-citation></ref><ref id="B9"><mixed-citation>Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bulletin of Experimental Biology and Medicine. 2021;171(2):179-189. DOI: https://doi.org/10.1007/s10517-021-05191-7</mixed-citation></ref><ref id="B10"><mixed-citation>Iacobini C, Vitale M, Pesce C, et al. Diabetic complications and oxidative stress: A 20-year voyage back in time and back to the future. Antioxidants. 2021;10(5):727. DOI: https://doi.org/10.3390/antiox10050727</mixed-citation></ref><ref id="B11"><mixed-citation>Papachristoforou E, Lambadiari V, Maratou E, et al. Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. Journal of Diabetes Research. 2020;2020:7489795. DOI: https://doi.org/10.1155/2020/7489795</mixed-citation></ref><ref id="B12"><mixed-citation>Du X, Matsumura T, Edelstein D, et al. Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. Journal of Clinical Investigation. 2003;112:1049-1057. DOI: https://doi.org/10.1172/JCI18127</mixed-citation></ref><ref id="B13"><mixed-citation>Garg SS, Gupta J. Polyol pathway and redox balance in diabetes. Pharmacological Research. 2022;182:106326. DOI: https://doi.org/10.1016/j.phrs.2022.106326</mixed-citation></ref><ref id="B14"><mixed-citation>Zhang ZY, Miao LF, Qian LL, et al. Molecular mechanisms of glucose fluctuations on diabetic complications. Frontiers in Endocrinology. 2019;10:640. DOI: https://doi.org/10.3389/fendo.2019.00640</mixed-citation></ref><ref id="B15"><mixed-citation>Ramasamy R, Shekhtman A, Schmidt AM. The RAGE/DIAPH1 signaling axis &amp;amp; implications for the pathogenesis of diabetic complications. International Journal of Molecular Sciences. 2022;23(9):4579. DOI: https://doi.org/10.3390/ijms23094579</mixed-citation></ref><ref id="B16"><mixed-citation>Demirtas L, Guclu A, Erdur FM, et al. Apoptosis, autophagy &amp;amp; endoplasmic reticulum stress in diabetes mellitus. Indian Journal of Medical Research. 2016;144(4):515-524. DOI: https://doi.org/10.4103/0971-5916.200887</mixed-citation></ref><ref id="B17"><mixed-citation>Pourvali K, Abbasi M, Mottaghi A. Role of superoxide dismutase 2 gene Ala16Val polymorphism and total antioxidant capacity in diabetes and its complications. Avicenna Journal of Medical Biotechnology. 2016;8(2):48-56.</mixed-citation></ref><ref id="B18"><mixed-citation>M&amp;ouml;llsten A, Marklund SL, Wessman M, et al. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes. 2007;56(1):265-269. DOI: https://doi.org/10.2337/db06-0698</mixed-citation></ref><ref id="B19"><mixed-citation>Nomiyama T, Tanaka Y, Piao L, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. Journal of Human Genetics. 2003;48(3):138-141. DOI: https://doi.org/10.1007/s100380300021</mixed-citation></ref><ref id="B20"><mixed-citation>Liu L, Zheng T, Wang N, et al. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Molecular and Cellular Biochemistry. 2009;322(1-2):87-91. DOI: https://doi.org/10.1007/s11010-008-9943-x</mixed-citation></ref><ref id="B21"><mixed-citation>World Health Organization. Global report on diabetes: executive summary (No. WHO/NMH/NVI/16.3). World Health Organization; 2016.</mixed-citation></ref><ref id="B22"><mixed-citation>Azarova I, Klyosova E, Polonikov A. Association between RAC1 gene variation, redox homeostasis and type 2 diabetes mellitus. European Journal of Clinical Investigation. 2022;52(8):13792. DOI: https://doi.org/10.1111/eci.13792</mixed-citation></ref><ref id="B23"><mixed-citation>Sol&amp;eacute; X, Guin&amp;oacute; E, Valls J, et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928-1929. DOI: https://doi.org/10.1093/bioinformatics/btl268</mixed-citation></ref><ref id="B24"><mixed-citation>Bastaki M, Huen K, Manzanillo P, et al. Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenetics and Genomics. 2006;16(4):279-286. DOI: https://doi.org/10.1097/01.fpc.0000199498.08725.9c</mixed-citation></ref><ref id="B25"><mixed-citation>Sutton A, Imbert A, Igoudjil A, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenetics and Genomics. 2005;15(5):311-319. DOI: https://doi.org/10.1097/01213011-200505000-00006</mixed-citation></ref><ref id="B26"><mixed-citation>Valenti L, Conte D, Piperno A, et al. The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. Journal of Medical Genetics. 2004;41(12):946-950. DOI: https://doi.org/10.1136/jmg.2004.019588</mixed-citation></ref><ref id="B27"><mixed-citation>Hiroi S, Harada H, Nishi H, et al. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochemical and Biophysical Research Communications. 1999;261(2):332-339. DOI: https://doi.org/10.1006/bbrc.1999.1036</mixed-citation></ref><ref id="B28"><mixed-citation>Landi S, Gemignani F, Neri M, et al. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. International Journal of Cancer. 2007;120(12):2739-2743. DOI: https://doi.org/10.1002/ijc.22590</mixed-citation></ref><ref id="B29"><mixed-citation>Choi JY, Neuhouser ML, Barnett MJ, et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis. 2008;29(5):964-970. DOI: https://doi.org/10.1093/carcin/bgn056</mixed-citation></ref><ref id="B30"><mixed-citation>Wiener HW, Perry RT, Chen Z, et al. A polymorphism in SOD2 is associated with development of Alzheimer&amp;#39;s disease. Genes, Brain and Behavior. 2007;6(8):770-775. DOI: https://doi.org/10.1111/j.1601-183x.2007.00308.x</mixed-citation></ref><ref id="B31"><mixed-citation>Yao D, Taguchi T, Matsumura T, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 2007;282(42):31038-31045. DOI: https://doi.org/10.1074/jbc.M704703200</mixed-citation></ref><ref id="B32"><mixed-citation>Hammes HP, Feng Y, Pfister F, et al. Diabetic retinopathy: targeting vasoregression. Diabetes. 2011;60(1):9-16. DOI: https://doi.org/10.2337/db10-0454</mixed-citation></ref><ref id="B33"><mixed-citation>Abu-El-Asrar AM, Dralands L, Missotten L, et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. Investigative Ophthalmology and Visual Science. 2004;45(8):2760-2766. DOI: https://doi.org/10.1167/iovs.03-1392</mixed-citation></ref><ref id="B34"><mixed-citation>Tien T, Zhang J, Muto T, et al. High glucose induces mitochondrial dysfunction in retinal muller cells: Implications for diabetic retinopathy. Investigative Ophthalmology and Visual Science. 2017;58:2915-2921. DOI: https://doi.org/10.1167/iovs.16-21355</mixed-citation></ref><ref id="B35"><mixed-citation>Sasaki M, Ozawa Y, Kurihara T, et al. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia. 2010;53:971-979. DOI: https://doi.org/10.1007/s00125-009-1655-6</mixed-citation></ref><ref id="B36"><mixed-citation>Sohn EH, van Dijk HW, Jiao C, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(9):E2655-E2664. DOI: https://doi.org/10.1073/pnas.1522014113</mixed-citation></ref><ref id="B37"><mixed-citation>&amp;nbsp;</mixed-citation></ref></ref-list></back></article>